ARL6IP1 Gene SPG61 Genetic Test
Welcome to DNA Labs UAE, where we offer the ARL6IP1 Gene SPG61 Genetic Test. This test is designed to diagnose a subtype of hereditary spastic paraplegia called SPG61. Hereditary spastic paraplegia is characterized by progressive weakness and stiffness in the lower limbs.
Test Details
The ARL6IP1 (ADP-ribosylation factor-like 6 interacting protein 1) gene is associated with SPG61. To analyze this gene, we use NGS (Next-Generation Sequencing) technology, which allows us to analyze multiple genes simultaneously and identify genetic variations or mutations.
Test Components
- Price: 4400.0 AED
- Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
- Report Delivery: 3 to 4 Weeks
- Method: NGS Technology
- Test Type: Neurological Disorders
- Doctor: Neurologist
- Test Department: Genetics
Pre Test Information
Prior to undergoing the ARL6IP1 Gene SPG61 NGS Genetic DNA Test, it is important to provide the clinical history of the patient. Additionally, a Genetic Counselling session will be conducted to draw a pedigree chart of family members affected with ARL6IP1 Gene SPG61.
Test Process
The NGS genetic test for ARL6IP1 gene SPG61 involves obtaining a DNA sample, typically through a blood sample or saliva sample, from the individual undergoing testing. The DNA sample is then sequenced using NGS technology to identify any variations or mutations in the ARL6IP1 gene.
Results and Benefits
The results of the NGS genetic test can provide valuable information about the presence or absence of specific mutations in the ARL6IP1 gene associated with SPG61. This information can help in confirming a diagnosis, providing accurate genetic counseling, and guiding treatment options for individuals with SPG61.
Test Name | ARL6IP1 Gene SPG61 Genetic Test |
---|---|
Components | |
Price | 4400.0 AED |
Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card o |
Report Delivery | 3 to 4 Weeks |
Method | NGS Technology |
Test type | Neurological Disorders |
Doctor | Neurologist |
Test Department: | Genetics |
Pre Test Information | Clinical History of Patient who is going for ARL6IP1 Gene SPG61 NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with ARL6IP1 Gene SPG61 |
Test Details |
ARL6IP1 (ADP-ribosylation factor-like 6 interacting protein 1) is a gene that is associated with a subtype of hereditary spastic paraplegia called SPG61. Hereditary spastic paraplegia is a group of genetic disorders characterized by progressive weakness and stiffness in the lower limbs. NGS (Next-Generation Sequencing) genetic testing is a method used to analyze multiple genes simultaneously to identify genetic variations or mutations. It is a more comprehensive and efficient approach compared to traditional Sanger sequencing. NGS can be used to identify specific mutations in the ARL6IP1 gene that are associated with SPG61. The NGS genetic test for ARL6IP1 gene SPG61 involves obtaining a DNA sample, typically through a blood sample or saliva sample, from the individual undergoing testing. The DNA sample is then sequenced using NGS technology to identify any variations or mutations in the ARL6IP1 gene. The results of the NGS genetic test can provide valuable information about the presence or absence of specific mutations in the ARL6IP1 gene associated with SPG61. This information can help in confirming a diagnosis, providing accurate genetic counseling, and guiding treatment options for individuals with SPG61. |